GreenMobility expects group profit in 2024: New strategy consolidates core markets and ensures no new capital is needed for 2023
Company Announcement no. 118 – 2023
Copenhagen, January 10th, 2023
GreenMobility expects group profit in 2024: New strategy consolidates core markets and ensures nonew capital is needed for 2023
From its original launch in 2016, GreenMobility has always been a growth company, where new market expansion has been funded by capital raises over time. Given the current uncertainties in the market, including among other things increased interest rates and cost of operation, changes in financial markets and reduced consumer spending have made GreenMobility focus on profitability across its core markets.
As a result, GreenMobility will close two of its markets and focus on its stronger core markets to extend the run-rate and boost the overall effort to bring the group to a break-even level. With the adjusted strategy, GreenMobility ensures that no new capital is needed in 2023.
Highlights of the new strategy
- Closing of its markets in Sweden and Germany to consolidate the business in existing strong markets
- Move cars to markets with higher revenue per car to support a stronger business foundation
- No new capital is required in 2023, due to extended liquidity run rate
- Close in on breakeven by late 2023 and expect group profitability in 2024 as the first fully electric and European carsharing company
- Demonstrate that the green transition can be profitable by building increased operational strength
- Continue to grow significantly with the current adjusted plan
- 2025 aspirations of 10,000 cars in 35 cities is maintained but postponed in time
The board and management of GreenMobility have decided to effectively close the company’s Swedish and German markets and thus adjust the current operational business. The two markets are the most cash intensive of GreenMobility’s markets. With two closed markets, the group now has the flexibility to bolster high-revenue markets and will relocate the electric fleet from the closing markets to realize and benefit from the growing demand in other existing markets. GreenMobility expects to finalize the German and Swedish markets and foresees an effective relocation and re-activation of the electric fleet in other markets during Q1-2023.
With the new strategy, GreenMobility expects that the group will get closer to a break-even level by the end of 2023, and the continued sufficient liquidity based on the existing capital will secure the operation for at least 2023. Correspondingly, GreenMobility has no plans or forecast any needs for raising new capital in 2023.
Now, GreenMobility expects 2024 to prove full-year profitability for the group reflecting the existing business’ expected growth and the developments of the markets.
GreenMobility leaves its long-term ambition of leading the market for sustainable carsharing in Europe unchanged. However, the aspiration for 35 cities and 10,000 EV’s by 2025 will be extended until 2030 due to complicated operational and financial market conditions and other external factors concerning the entire mobility industry.
Today, GreenMobility can reveal a strong position in both its operational day-to-day business with more than 200.000 customers across many cities in Europa and has proven a solid “Year over Year '' revenue growth of 60 pct. for the past two years. The group expects growth at a similar level for the coming year in existing markets, aiming for being the first European electric carsharing company to demonstrate profitability in 2024.
Contact and further information
Anders Wall, CEO (interim) & Group CFO, +45 25 40 30 20, e-mail: email@example.com
GreenMobility offers modern urbanites easy, flexible, and sustainable transport in the form of electric shared city cars. Users have access to these cars via the GreenMobility app. Trips are paid per minute, through minute packages, on a daily basis or through a subscription. Today, GreenMobility operates a total of 1,600 EVs in Copenhagen, Aarhus, Malmö, Gothenburg, Antwerp, Gent, Brussels, Helsinki, Amsterdam, Düsseldorf and Cologne. More than 200,000 people are registered as customers at GreenMobility.
Driven by global megatrends, GreenMobility sees a rapidly growing market for carsharing in large cities that demand green transport for their citizens and aim to reduce the number of private cars. GreenMobility’s ambition is to be among the leading global operators of green shared mobility solutions. GreenMobility is publicly listed for trading on the Nasdaq Main Market Copenhagen in Denmark.
- GreenMobility expects group profit in 2024 - New strategy consolidates core markets and ensures no new capital is needed for 2023
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease8.2.2023 22:01:00 CET | Press release
The two induction cohorts missed the co-primary endpoints of clinical remission and endoscopic response at Week 10In the maintenance phase, filgotinib 200mg once daily achieved the co-primary endpoints of clinical remission and endoscopic response at Week 58The safety findings were generally consistent with the known profile of filgotinib in rheumatoid arthritis (RA) and ulcerative colitis (UC)Galapagos decided not to submit a Marketing Authorization Application in Europe based on these topline dataGalapagos remains fully committed to filgotinib, a JAK1 preferential inhibitor orally administered once daily, and its approved indications, RA and UC, and is on track to start a Phase 3 trial in axial spondyloarthritis (AxSpA) later this year Mechelen, Belgium; 8February2023, 22:01CET; regulated information; Galapagos NV (Euronext & NASDAQ: GLPG) todayannouncedthe topline results from DIVERSITY,a global Phase 3 trial to evaluate the safety and efficacy of filgotinib,100mg or 200mg once dail
X8 AG Submits a Swiss Fintech Licence Application8.2.2023 21:21:16 CET | Press release
X8 AG submitted the application for a Swiss FinTech license according to Art. 1b Banking Act with the intention of operating a regulated global stablecoin system BAAR, Switzerland, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The X8 AG team has successfully submitted the application to FINMA, the Swiss Financial Market Supervisory Authority, for the Swiss FinTech license according to Article 1b Banking Act. This marks an important step for X8 AG on its way to become a fully regulated global stablecoin system and significantly differentiating itself from the current non-regulated crypto space. Switzerland offers one of the most advanced regulatory frameworks for digital assets. X8 AG believes that designing its stablecoin system under Swiss law is the best starting point to achieve a global X8 cross-border framework for payments. Full compliance with the Swiss regulatory framework strengthens the high standards of protection for clients. X8 AG aims to empower users and their money with frictionles
GN Store Nord announces intention to initiate a rights issue8.2.2023 20:08:16 CET | Press release
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL This announcement does not constitute an offering memorandum or a prospectus as defined by Regulation (EU) No. 2017/1129 of 14 June 2017. The offer to acquire securities pursuant to the offering is made, and any investor should make their investment decision, solely on the basis of information that is contained in the prospectus to be made generally available in Denmark in connection with the offering. GN Store Nord announces intention to initiate a rights issue In accordance with our announcement on November 11, 2022, GN has conducted a comprehensive review of the appropriate capital structure. In light of the current macroeconomic environment and GN’s leverage, GN announces today that it intends to raise gross proceeds of DKK 7 billion in the first half
Nokia Corporation: Repurchase of own shares on 08.02.20238.2.2023 20:00:00 CET | Press release
Nokia Corporation Stock Exchange Release 8 February 2023 at 21:00 EET Nokia Corporation: Repurchase of own shares on 08.02.2023 Espoo, Finland – On 8 February 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL282,2294.39CEUX20,3804.39AQEU6,3784.39TQEX5,0134.38Total314,0004.39 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 January 2023
Interim report 2022/23 - 15% revenue growth and DKK 145 million operating profit (+25%) for the first half following a challenging second quarter8.2.2023 18:57:07 CET | Press release
ANNOUNCEMENT NO. 234 9 February 2023 Interim report for the first half of 2022/23 15% revenue growth and DKK 145 million operating profit (+25%) for the first half following a challenging second quarter Steen Søndergaard, CEO: “Following a very satisfactory 2021/22 with historically high revenue and operating profit growth rates, revenue for the first half of 2022/23 unfortunately disappointed, despite 15% growth. Second quarter sales of instruments, particularly in the North American market, were challenged by a generally more subdued investment sentiment in our primary business segment, cell-based therapy. Our order intake was mainly impacted by weakened demand from capital-sensitive development companies. On the other hand, we saw continued satisfactory growth in sales of consumables and services. Despite the unfavourable market conditions, our earnings continued to grow. While our market is currently affected by the prevailing macroeconomic environment, we have a strong underlying